Medbox Appoints Ambassador Ned L. Siegel As Chairman of the Board
December 31 2014 - 8:00AM
Business Wire
Medbox, Inc. (OTCQB:MDBX) (www.medbox.com), a leading dispensary
infrastructure/licensing specialist, patented technology provider,
and partner to the cannabis industry, announced today that
Ambassador Ned L. Siegel (Ret.) has been appointed as Chairman of
the Company’s Board of Directors.
Ambassador Siegel was appointed by then President George W.
Bush, as the U.S. Ambassador to the Commonwealth of the Bahamas
from October 2007 to January 2009. He was also appointed by
President Bush to serve under Ambassador John R. Bolton at the
United Nations in New York, serving as the Senior Advisor to the
U.S. Mission and as the United States representative to the 61st
Session of the United Nations General Assembly. Prior to his
ambassadorship, he was appointed to the Board of Directors of the
Overseas Private Investment Corporation (OPIC). In addition to his
public service, Ambassador Siegel has over 30 years of
entrepreneurial successes. Presently, he is Chairman of the Board
of The Siegel Group, a multi-disciplined international business
management advisory firm specializing in infrastructure, real
estate, ports, energy, utilities, technology and financial
services.
Mr. Guy Marsala, Medbox CEO, commented, “Over the course of this
year, Medbox has evolved from an entrepreneurial firm to a
professionally managed organization with a world class management
team and Board of Directors. With the recent wins of 8 provisional
licenses for cultivation facilities in Nevada, and the opening of
our first dispensary in Portland, my main focus must be to continue
to grow our company and attract the right capital to support this
growth. As such, we have appointed Ambassador Siegel as our Board
Chairman so I can focus on these growth initiatives and drive
shareholder value.”
Ambassador Siegel stated, “I am honored to accept the position
as Chairman of the Board of Medbox. Having been a board member
since April of this year, I believe that Medbox is in a unique
position in the cannabis industry to properly advise investors and
entrepreneurs as to how to obtain the required licenses to operate,
and subsequently how to manage their businesses with the highest
levels of safety, security, profitability and best practices. I
look forward to continuing to work with the Medbox team to reach
our full potential.”
About Medbox, Inc.
Medbox, Inc. (“MDBX” or the “Company”) is the leading dispensary
infrastructure and licensing specialist, patented technology
provider, and partner to the cannabis industry. Headquartered in
Los Angeles, CA, Medbox, through its wholly owned subsidiary,
Medicine Dispensing Systems, offers its patented systems, software
and consulting services to pharmacies, alternative medicine
dispensaries and local governments in the U.S. In addition, through
its wholly owned subsidiary, Vaporfection International, Inc.
(www.vaporfection.com), the company offers an industry award
winning medical line of vaporizer products. Medbox, through its
newly established subsidiaries, is also developing ancillary
services tailored to the alternative medicine industry, including
real estate acquisitions and subsequent lease programs to
alternative medicine dispensaries and cultivation centers, and
alternative medicine dispensary and cultivation management
services.
Forward-Looking Statements
The statements in this press release constitute forward-looking
statements within the meaning of federal securities laws. Such
statements are based on our current beliefs and expectations and
are inherently subject to significant business, economic and
competitive uncertainties and contingencies, many of which are
beyond our control. In addition, such forward-looking statements
are subject to assumptions with respect to future business
strategies and decisions that are subject to change. Potential
risks and uncertainties include, but are not limited to, technical
advances in the industry as well as political and economic
conditions present within the industry. We do not take any
obligation to update any forward-looking statement to reflect
events or developments after a forward looking statement was
made.
Contact Information
Investor Relations:Stephen HartHayden
IR917-658-7878hart@haydenir.com
Medbox:For more information on Medbox, please call (800)
762-1452.
Investor Relations:Hayden IRStephen Hart,
917-658-7878hart@haydenir.comorMedbox, 800-762-1452